Torigoe, H., Shien, K., Takeda, T., Yoshioka, T., Namba, K., Sato, H., . . . Toyooka, S. (2018). Therapeutic strategies for afatinib‐resistant lung cancer harboring HER2 alterations. Cancer Sci.
Chicago Style CitationTorigoe, Hidejiro, et al. "Therapeutic Strategies for Afatinib‐resistant Lung Cancer Harboring HER2 Alterations." Cancer Sci 2018.
Cita MLATorigoe, Hidejiro, et al. "Therapeutic Strategies for Afatinib‐resistant Lung Cancer Harboring HER2 Alterations." Cancer Sci 2018.
Atenció: Aquestes cites poden no estar 100% correctes.